Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-State, Tribal, Local and Territorial (STLT) Subcommittee, 11576 [2017-03626]
Download as PDF
<![CDATA[
11576
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
Engagement Strategies’’, IP17–002 and
‘‘Rapid-Cycle Survey Collaborative for
Provider Input on Immunization
Issues’’, IP17–003.
CONTACT PERSON FOR MORE INFORMATION:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone:
(404) 718–8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03628 Filed 2–23–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 10:00 a.m.–11:30 a.m.,
EDT, March 21, 2017.
PLACE: This meeting will be held by
teleconference.
STATUS: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment, which is tentatively
scheduled from 11:15 a.m.–11:20 a.m.
EDT. To participate on the
teleconference, please dial (855) 644–
0229 and enter code 1482483.
PURPOSE: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategies, future
needs, and challenges faced by State,
Tribal, Local and Territorial health
agencies, and will provide guidance on
opportunities for CDC.
MATTERS FOR DISCUSSION: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
Jkt 241001
Jose Montero, MD, MPH, Designated
Federal Officer, STLT Subcommittee,
ACD, CDC, 4770 Buford Highway, MS
E70, Atlanta, Georgia 30341, Telephone
(404) 498–0300, Email:
OSTLTSDirector@cdc.gov. Please
submit comments to OSTLTSDirector@
cdc.gov no later than March 17, 2017.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2017–03626 Filed 2–23–17; 8:45 am]
Centers for Disease Control and
Prevention
17:20 Feb 23, 2017
CONTACT PERSON FOR MORE INFORMATION:
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
health department of the future, other
emerging challenges and how CDC can
best support STLT health departments
in the transforming health system.
The agenda is subject to change as
priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0733]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Proposed Project
Early Hearing Detection and
Intervention (EHDI) Follow-up Survey
(OMB Control No. 0920–0733,
Expiration Date: 8/31/2016)—
Reinstatement with Change—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
NCBDDD promotes the health of
babies, children, and adults, with a
focus on preventing birth defects and
developmental disabilities and
optimizing the health outcomes of those
with disabilities. As part of these efforts
NCBDDD is actively involved in
addressing the early identification of
hearing loss among newborns and
infants. Congenital hearing loss is a
common birth defect that affects 1 to 3
per 1,000 live births, or approximately
12,000 children across the United States
annually. Studies have shown that
children with a delayed diagnosis of
hearing loss can experience preventable
delays in speech, language, and
cognitive development. To ensure
children with hearing loss are identified
as soon as possible, many states and
United States (U.S.) territories have
implemented Early Hearing Detection
and Intervention (EHDI) programs and
enacted laws related to infant hearing
screening. The majority of these EHDI
programs have adopted the ‘‘1–3–6’’
plan, which consists of three core goals:
(1) Screening all infants for hearing loss
before 1 month of age, (2) ensuring
diagnostic audiologic evaluation before
3 months of age for those who do not
pass the screening, and (3) enrollment
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Page 11576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03626]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--State, Tribal, Local and Territorial (STLT)
Subcommittee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
TIME AND DATE: 10:00 a.m.-11:30 a.m., EDT, March 21, 2017.
PLACE: This meeting will be held by teleconference.
STATUS: This meeting is open to the public, limited only by the
availability of telephone ports. The public is welcome to participate
during the public comment, which is tentatively scheduled from 11:15
a.m.-11:20 a.m. EDT. To participate on the teleconference, please dial
(855) 644-0229 and enter code 1482483.
PURPOSE: The Subcommittee will provide advice to the CDC Director
through the ACD on strategies, future needs, and challenges faced by
State, Tribal, Local and Territorial health agencies, and will provide
guidance on opportunities for CDC.
MATTERS FOR DISCUSSION: The STLT Subcommittee members will discuss
progress on implementation of ACD-adopted recommendations related to
the health department of the future, other emerging challenges and how
CDC can best support STLT health departments in the transforming health
system.
The agenda is subject to change as priorities dictate.
CONTACT PERSON FOR MORE INFORMATION: Jose Montero, MD, MPH, Designated
Federal Officer, STLT Subcommittee, ACD, CDC, 4770 Buford Highway, MS
E70, Atlanta, Georgia 30341, Telephone (404) 498-0300, Email:
OSTLTSDirector@cdc.gov. Please submit comments to
OSTLTSDirector@cdc.gov no later than March 17, 2017.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-03626 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P
